The government gave the green light Friday to a plan for blood transfusions including platelets created from artificially derived stem cells to patients with intractable diseases.A team of researchers from Kyoto University will begin a transfusion trial using so-called induced pluripotent stem cells. It will be the 4th clinical test plan using iPS cells approved by the health ministry and the first using blood components.Researchers are expecting such cells to become a new source for platelets, replacing transfusions of donated blood that tend to be deficient."We will prepare for the tests …READ FULL ARTICLE
